# A Clinical Study to Evaluate The Safety and Effectiveness of Performing 0.50 Diopter Astigmatism Correction on the Commercially Available RxSight Light Adjustable Lens (LAL)

> **NCT04005586** · NA · COMPLETED · sponsor: **RxSight, Inc.** · enrollment: 25 (actual)

## Conditions studied

- Aphakia
- Cataract

## Interventions

- **DEVICE:** Light Delivery Device (LDD)

## Key facts

- **NCT ID:** NCT04005586
- **Lead sponsor:** RxSight, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-07-01
- **Primary completion:** 2020-03-01
- **Final completion:** 2020-03-01
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2021-06-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04005586

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04005586, "A Clinical Study to Evaluate The Safety and Effectiveness of Performing 0.50 Diopter Astigmatism Correction on the Commercially Available RxSight Light Adjustable Lens (LAL)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04005586. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*